Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
655
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus – Letters

Longitudinally extensive transverse myelitis after covid vaccination: Response to letter

Seyed Farzad Maroufia Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Fereshteh Naderi Behdanib Department of Neurology, Ziaeian Hospital, Tehran University of Medical Science, Tehran, IranView further author information
,
Fatemeh Rezaniac Neurosciences Department, St Vincent’s Hospital, Melbourne, AustraliaView further author information
,
Samaneh Tanhapour Khotbehsarad Faculty of Medicine, Iran University of Medical Sciences, Tehran, IranORCID Iconhttps://orcid.org/0000-0002-1574-8682View further author information
ORCID Icon &
Zahra Mirzaasgarie Neurology Department, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4046-8471View further author information
ORCID Icon
Article: 2096378 | Received 09 Jun 2022, Accepted 25 Jun 2022, Published online: 12 Jul 2022

References

  • Finsterer J. SARS-CoV-2 vaccinations complicated by transverse myelitis. Human Vaccines & Immunotherapeutics. 2022;1–1. doi:10.1080/21645515.2022.2057162.
  • Maroufi SF, Naderi Behdani F, Rezania F, Tanhapour Khotbehsara S, Mirzaasgari Z. Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature. Hum Vaccines Immunotherapeutics. 2022;18:2040239.
  • Li X, Raventós B, Roel E, Pistillo A, Martinez-Hernandez E, and Delmestri A, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022;376:e068373.
  • Tabatabaee S, Rezania F, Alwedaie SMJ, Malekdar E, Badi Z, and Tabatabaei SM, et al. Post COVID-19 vaccination Guillain-Barre syndrome: three cases. Hum Vaccines Immunotherapeutics. 2022;18:1–5.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.